Effects of low-fat diet on serum lipids in premenopausal and postmenopausal women: A meta-analysis of randomized controlled trials

Menopause

Volumn 21, Issue 1, 2014, Pages 89-99

  Wu, Liping ^a   Ma, Di ^a   Walton Moss, Benita ^b   He, Zhong ^c  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Chinese Academy of Medical Sciences Peking Union Medical College   (China)

Author keywords

Low fat diet; Menopause; Meta analysis; Serum lipids

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CINAHL; COCHRANE LIBRARY; COMPARATIVE STUDY; DATA EXTRACTION; EMBASE; HUMAN; INTERVENTION STUDY; LOW FAT DIET; MEDLINE; META ANALYSIS; POSTMENOPAUSE; PRACTICE GUIDELINE; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, FAT-RESTRICTED; DIETARY FATS; FEMALE; HUMANS; POSTMENOPAUSE; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGLYCERIDES;

EID: 84891832606     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e318291f5c2     Document Type: Article

References (35)

1. Cardiovascular diseases (CVDs). Available at: http://www.who.int/ mediacentre/factsheets/fs317/en/index.html. Accessed August 31, 2012.
2. Stock EO, Redberg R. Cardiovascular disease in women. Curr Probl Cardiol 2012;37:450-526.
3. Stevenson JC. A womans journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement. Maturitas 2011;70:197-205.
4. Yang XP, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens 2011;20:133-138.
5. Pai JK, Manson JE. Acceleration of cardiovascular risk during the late menopausal transition. Menopause 2013;20:1-2.
6. Briel M, Ferreira-Gonzalez I, You JJ, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ 2009;338:b92.
7. De Caterina R, Scarano M, Marfisi R, et al. Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2010;55:198-211.
8. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-372.
9. Jacobs DJ, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990;131:32-47.
10. Weiss AM. Cardiovascular disease in women. Prim Care 2009;36:73-102, viii.
11. Hooper L, Summerbell CD, Thompson R, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2012;5:CD002137.
12. Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102: 2284-2299.
13. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007;115:1481-1501.
14. Senechal M, Bouchard DR, Dionne IJ, Brochu M. The effects of lifestyle interventions in dynapenic-obese postmenopausal women. Menopause 2012;19:1015-1021.
15. Ginsberg HN, Kris-Etherton P, Dennis B, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol 1998;18:441-449.
16. Bhargava A. Fiber intakes and anthropometric measures are predictors of circulating hormone, triglyceride, and cholesterol concentrations in the womens health trial. J Nutr 2006;136:2249-2254.
17. Clifton PM, Noakes M, Keogh JB. Very low-fat (12%) and high monounsaturated fat (35%) diets do not differentially affect abdominal fat loss in overweight, nondiabetic women. J Nutr 2004;134:1741-1745.
18. Gerhard GT, Connor SL, Wander RC, Connor WE. Plasma lipid and lipoprotein responsiveness to dietary fat and cholesterol in premenopausal African American and white women. Am J Clin Nutr 2000;72:56-63.
19. Chen G, Heilbrun LK, Venkatramanamoorthy R, et al. Effects of low-fat and/or high fruit-and-vegetable diets on plasma levels of 8-isoprostane-F2in the Nutrition and Breast Health Study. Nutr Cancer 2004;50:155-160.
20. Barnard ND, Scialli AR, Bertron P, Hurlock D, Edmonds K, Talev L. Effectiveness of a low-fat vegetarian diet in altering serum lipids in healthy premenopausal women. Am J Cardiol 2000;85:969-972.
21. Svendsen OL, Hassager C, Christiansen C. Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women. Am J Med 1993;95:131-140.
22. Kelley GA, Kelley KS, Roberts S, Haskell W. Efficacy of aerobic exercise and a prudent diet for improving selected lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. BMC Med 2011;9:74.
23. Higgins JPT & Green S, Eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org.
24. Cochrane Heart Group. http://onlinelibrary.wiley.com/o/cochrane/clabout/ articles/VASC/frame.html.
25. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey SG. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011;CD001561.
26. Nordmann AJ, Suter-Zimmermann K, Bucher HC, et al. Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med 2011;124:841-851.e2.
27. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003;77:1146-1155.
28. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
30. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 4.2.6 [updated September 2006]. The Cochrane Library. Chichester, UK: John Wiley and Sons Ltd, 2006.
31. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Womens Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006;295:655-666.
32. Boyd NF, Martin LJ, Beaton M, Cousins M, Kriukov V. Long-term effects of participation in a randomized trial of a low-fat, high-carbohydrate diet. Cancer Epidemiol Biomarkers Prev 1996;5:217-222.
33. Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris- Etherton PM. Effects of the National Cholesterol Education Programs Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999;69:632-646.
34. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992;12: 911-919.
35. Bolanos R, Del CA, Francia J. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis. Menopause 2010;17:660-666.